1001 G Street NW
Suite 500 West
Washington, DC 20001
Philip Sayre is currently working at Keller and Heckman, LLP in Washington, D.C. He has over twenty-eight years of experience in the environmental field, and specializes in assessing risks of commercial nanomaterials and microbial biotechnology products under TSCA. He has participated as a lead in national and international regulatory test guideline work for nanomaterials.
Prior to joining Keller and Heckman, Dr. Sayre worked most recently as a Senior Scientist for the U.S. Environmental Protection Agency. In this capacity, he was involved in the health and ecological assessments of over 160 nanomaterial submissions that have been submitted to EPA for commercialization under TSCA. Dr. Sayre also worked on identifying hazards associated with many biotechnology submissions under Section 5 of TSCA, and was a lead author of the EPA guidance to be followed by biotechnology submitters under TSCA. Other positions held at EPA included those in OSWER, the SAB, and ORD. Prior to coming to EPA, Dr. Sayre completed biotechnology and chemical ecotoxicity, exposure, and risk assessments under the National Environmental Policy Act (NEPA) at FDA.
His most recent publications include the following (additional publications available on request):
He serves as a reviewer for several toxicology and risk assessment journals, and is a current member of both SOT and SETAC.
© 2017 Keller and Heckman LLP. All rights reserved